Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Pozycja w akcjach #40612
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Cena akcji
$0.13607016
Ostatnia synchronizacja: 2024-09-10
Kapitalizacja rynkowa
$112.29K
Zmiana (1 dzień)
22.46%
Zmiana (1 rok)
0.00%
Kraj
GB
Handel BiVictriX Therapeutics Plc (BVX)

Kategoria

Historia stopy dywidendy dla BiVictriX Therapeutics Plc (BVX)
Stopa dywidendy (TTM) dla BiVictriX Therapeutics Plc (symbol akcji: BVX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla BiVictriX Therapeutics Plc (BVX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji